Simon; Iris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Simon; Iris.The latest application filed is for "method and means for typing a sample comprising cancer cells based on oncogenic signal transduction pathways".

Company Profile

1.8.17

Simon; Iris - Amsterdam N/A NL
Simon; Iris - San Francisco CA
Simon; Iris - Awstodam NL
Simon; Iris - Amstodam NL
Simon; Iris - San Franscisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and means for molecular classification of colorectal cancers Grant 10,036,070 - Roepman , et al. July 31, 2	2018-07-31
Method and Means for Typing a Sample Comprising Cancer Cells Based on Oncogenic Signal Transduction Pathways App 20170292162 - Sun; Tian ; et al.	2017-10-12
Methods for Molecular Classification of BRCA-Like Breast and/or Ovarian Cancer App 20170058351 - Linn; Sabine ; et al.	2017-03-02
Methods and Means for Typing a Sample Comprising Cancer Cells Based on Oncogenic Signal Transduction Pathways App 20130302321 - Sun; Tian ; et al.	2013-11-14
Methods and Means for Molecular Classification of Colorectal Cancers App 20130296191 - Roepman; Paul ; et al.	2013-11-07
Ovr115 Antibody Compositions And Methods Of Use App 20130022539 - Pilkington; Glenn ; et al.	2013-01-24
Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer Risk App 20120329079 - Simon; Iris ; et al.	2012-12-27
Pro104 Antibody Compositions and Methods of Use App 20120263647 - Papkoff; Jackie ; et al.	2012-10-18
Ovr115 antibody compositions and methods of use Grant 8,207,311 - Pilkington , et al. June 26, 2	2012-06-26
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk Grant 8,148,093 - Simon , et al. April 3, 2	2012-04-03
Pro104 antibody compositions and methods of use Grant 8,080,650 - Papkoff , et al. December 20, 2	2011-12-20
OVR110 Antibody Compositions and Methods of Use App 20100209438 - Pilkington; Glenn ; et al.	2010-08-19
Ovr110 antibody compositions and methods of use Grant 7,619,068 - Pilkington , et al. November 17, 2	2009-11-17
PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk App 20090232732 - SIMON; IRIS ; et al.	2009-09-17
Pro104 Antibody Compositions and Methods of Use App 20090220424 - Papkoff; Jackie ; et al.	2009-09-03
Ovr110 Antibody Compositions And Methods For Use App 20090136490 - Pilkington; Glenn ; et al.	2009-05-28
Pro104 antibody compositions and methods of use Grant 7,479,546 - Papkoff , et al. January 20, 2	2009-01-20
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk Grant 7,294,704 - Simon , et al. November 13, 2	2007-11-13
Ovr110 antibody compositions and methods of use App 20070178101 - Pilkington; Glenn ; et al.	2007-08-02
Ovr115 antibody compositions and methods of use App 20070104647 - Pilkington; Glenn ; et al.	2007-05-10
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk App 20050124012 - Simon, Iris ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.